Lassen therapeutics launches to discover and develop novel antibody therapeutics including lead program targeting il-11 to treat fibrosis and oncology

Lassen therapeutics today announced it has emerged from stealth and secured $31 million in series a financing to develop antibodies as potential treat

ACHV Ratings Summary

ACHV Quant Ranking